Earnings

All articles by Earnings

Bayer’s pharma sales rise thanks to Nubeqa and radiology business
Bayer’s pharma sales rise thanks to Nubeqa and radiology business
Jack O'Brien
May 10, 2022
10:30 am

The company released its earnings less than two weeks after its CEO survived a non-binding shareholder vote.

Moderna reports $6.1B in revenue, Regeneron earnings led by Dupixent sales
Moderna reports $6.1B in revenue, Regeneron earnings led by Dupixent sales
Jack O'Brien
May 4, 2022
10:22 am

Regeneron’s revenues rose by double digits, though its net income fell by double digits.

Earnings season continues with Biogen bust, Pfizer boom
Earnings season continues with Biogen bust, Pfizer boom
Jack O'Brien
May 3, 2022
10:42 am

Biogen CEO and Aduhelm out; Paxlovid generates $1.5B in sales for Pfizer.

Pharma earnings roundup: AstraZeneca, BMS, AbbVie report
Pharma earnings roundup: AstraZeneca, BMS, AbbVie report
Jack O'Brien
April 29, 2022
12:33 pm

Notably, AstraZeneca said that total revenue from its COVID-19 medicines is likely to decline by a “low-to-mid twenties percentage.”

Gilead Q1 revenue surges to $6.6B on increased demand for Biktarvy and Veklury
Gilead Q1 revenue surges to $6.6B on increased demand for Biktarvy and Veklury
Jack O'Brien
April 29, 2022
9:12 am

Despite top-line growth, sales for Truvada and hep-C products fell by double-digits.

Merck records nearly $16B in sales, Eli Lilly revenues grow 15%
Merck records nearly $16B in sales, Eli Lilly revenues grow 15%
Jack O'Brien
April 28, 2022
10:29 am

Lilly generated $660 million in revenue from its COVID antibody treatment, while Merck’s oral antiviral treatment produced sales of $3.2 billion.

Amgen revenues jump 6% thanks to global sales, COVID collaboration
Amgen revenues jump 6% thanks to global sales, COVID collaboration
Jack O'Brien
April 27, 2022
5:00 pm

The company said that it saw the impact of the pandemic ‘recede’ in the U.S. during March and April, leading to ‘improved demand patterns.’

GSK records strong start to 2022 thanks to COVID, shingles treatments
GSK records strong start to 2022 thanks to COVID, shingles treatments
Jack O'Brien
April 27, 2022
10:42 am

The British pharma giant released its earnings two weeks after announcing a deal to acquire Sierra Oncology for $1.9 billion.

Roche sales jump in Q1, despite slowing demand for COVID products
Roche sales jump in Q1, despite slowing demand for COVID products
Jack O'Brien
April 25, 2022
10:29 am

The company also announced that its breast cancer drug, giredestrant, did not meet its primary endpoint during Phase 2 trials.

COVID testing demand drives growth for Abbott’s diagnostics arm
COVID testing demand drives growth for Abbott’s diagnostics arm
Jack O'Brien
April 20, 2022
9:23 am

Global COVID testing-related sales totaled $3.3 billion during the quarter, led largely by continued demand for rapid testing products.

  • From Our Partners